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Familial hemiplegic migraine, episodic ataxia type 2 (EA2), and spinocerebellar ataxia type 6 are allelic disorders
of the CACNA1A gene (coding for the a1A subunit of P/Q calcium channels), usually associated with different
types of mutations (missense, protein truncating, and expansion, respectively). However, the finding of expansion
and missense mutations in patients with EA2 has blurred this genotype-phenotype correlation. We report the first
functional analysis of a new missense mutation, associated with an EA2 phenotype—that is, TrC transition of nt
4747 in exon 28, predicted to change a highly conserved phenylalanine residue to a serine at codon 1491, located
in the putative transmembrane segment S6 of domain III. Patch-clamp recording in HEK 293 cells, coexpressing
the mutagenized human a1A-2 subunit, together with human b4 and a2d subunits, showed that channel activity was
completely abolished, although the mutated protein is expressed in the cell. These results indicate that a complete
loss of P/Q channel function is the mechanism underlying EA2, whether due to truncating or to missense mutations.
Mutations of the CACNA1A gene, coding for the pore-
forming a1A subunit of voltage-gated P/Q Ca
2 channels,
were found to be responsible for three allelic disorders
with autosomal dominant inheritance: familial hemiple-
gic migraine (FHM [MIM 141500]), episodic ataxia type
2 (EA2 [MIM 108500]) (Ophoff et al. 1996), and spi-
nocerebellar ataxia type 6 (SCA6 [MIM 183086]) (Zhu-
chenko et al. 1997). The gene is expressed throughout
the brain and particularly in the cerebellar Purkinje and
granule cells (Westenbroek et al. 1995; Volsen et al.
1995). P/Q-type Ca2 channels play a prominent role in
controlling neurotransmitter release in many synapses
(Dunlap et al. 1995). Furthermore, their localization in
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dendrites and cell bodies suggests additional postsynap-
tic roles. FHM, characterized by hemiplegic migraine
attacks with or without interictal cerebellar signs, is as-
sociated with missense mutations in all families so far
reported (Ophoff et al. 1996; Battistini et al. 1999; Duc-
ros et al. 1999). EA2, with ataxia/vertigo episodes and
interictal cerebellar signs of variable severity, is most
often due to mutations disrupting the reading frame and/
or leading to premature stop (Ophoff et al. 1996; Denier
et al. 1999; Jen et al. 1999). SCA6, whose clinical fea-
tures widely overlap with those of EA2 (Jodice et al.
1997; Frontali et al. 1999; Frontali and Jodice, in press),
is caused by small expansions of the CAG-repeat se-
quence at the 3′ end of the gene (Zhuchenko et al. 1997).
However, patients with an EA2 phenotype were also
found to carry either a CAG expansion (Jodice et al.
1997) or missense mutations (Yue et al. 1997; Denier et
al. 1999; Friend et al. 1999), thus blurring the picture
of the above genotype/phenotype correlation.
The functional analysis of missense mutations causing
FHM showed different patterns of altered channel ac-
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Figure 1 Pedigree of the family with EA2 carrying the missense
CACNA1A mutation. Blackened circles indicate patients with EA2.
Chromosome-19–marker haplotypes, typed as previously reported
(Kern et al. 1994), are also shown. The proband (III-1), with a con-
genital strabismus surgically corrected, has had vertigo episodes since
age 5 years. At age 12 years, a progressive gait imbalance began with
subcontinuous vertigo exacerbated by rapid head movements and emo-
tional stress. Neurological examination at age 17 years showed gen-
eralized hypotonia, nystagmus on lateral gaze, impaired smooth pur-
suit, gait ataxia, and mild dysmetria. More recently, neurological
examination showed a complex dyskinetic movement of the right leg,
most likely of a dystonic type. The proband’s mother (II-2) had a
strabismus surgically corrected in infancy; her episodes, which began
at age 7 years, were more severe and prolonged in the past (with
vertigo, trunk ataxia, rotatory nystagmus on lateral and vertical gaze,
nausea, and vomiting) and milder and shorter recently. She has had
migraine attacks without aura since age 13 years. Neurological ex-
amination, at age 49 years, revealed interictal rotatory nystagmus on
lateral gaze, with impairment of smooth-eye pursuit, mild truncal
ataxia and dysmetria, and a writer’s cramp of the right hand. Appro-
priate informed consent was obtained by all family members analyzed.
Figure 2 Linear view of the a1A subunit of calcium channel,
coded by CACNA1A gene. Each of four domains (I-IV) has six trans-
membrane segments (S), and one pore-forming segment (P) between
S5 and S6. The F1491S mutation (squared F in the sequence) involves
the fourth amino acid in the sequence of segment III S6 (underlined),
immediately downstream from the end of the P-segment sequence
(italics).
tivity (Kraus et al. 1998; Hans et al. 1999). It has been
shown that the changes in single-channel function and
channel expression produced by different FHM muta-
tions can lead to opposite effects on Ca2 influx (Hans
et al. 1999). It is worth noting that only mutations that
are predicted to cause a reduction of Ca2 influx are
associated with a phenotype that includes cerebellar
ataxia in addition to FHM (Hans et al. 1999). Moreover,
a reduced channel availability has been reported for the
channels formed by the a1A subunit containing the SCA6
mutation—that is, an expanded polyglutamine repeat
(Matsuyama et al. 1999; Toru et al. 2000).
No functional analysis has as yet been performed on
mutations responsible for EA2. Most EA2 mutations are
predicted to produce a truncated protein and are highly
likely to be associated with a loss of channel function,
either because of difficulties in channel assembly or loss
of truncated polypeptides. Nothing is known about the
channel function in the presence of EA2 nontruncating
mutations such as the gly293arg mutation, located in
the putative P region of the I domain (Yue et al. 1997),
del Y1594/A1593D, in the putative S2 segment of do-
main IV (Denier et al. 1999), and Arg1666His, in the
IV S4 domain (Friend et al. 1999).
We report a family with EA2 (fig. 1) carrying a de
novo missense mutation in the transmembrane S6 seg-
ment of the III protein domain. The functional analysis
of the mutated a1A subunit showed that no P/Q type
Ca2 channel activity was detected, although protein ex-
pression is similar to that of wild type (wt), thus differ-
entiating this missense mutation from those associated
with FHM (Hans et al. 1999).
The mutation has been detected by SSCP analysis and
sequencing in two members of the family reported in
figure 1. SSCP analysis of patients’ DNA was performed,
according to published protocols (Orita et al. 1989; Rav-
nik-Glavac et al. 1994), on all 47 exons and intron-exon
junctions of CACNA1A gene (Ophoff et al. 1996) and
on the alternative exon 37 (Trettel et al. 2000). Analysis
of exon 28 showed an aberrantly migrating fragment in
the proband (III-1) and in her mother (II-2). Its sequenc-
ing showed a TrC transition at position 4747 in the
CACNA1A sequence, reported by Ophoff et al. (1996)
(GenBank). The aberrant migration was not found in
50 random Italian subjects, whose DNA was analyzed
by the Amplification Refractory Mutation System. The
mutation predicts a substitution of a highly conserved
phenylalanine, a nonpolar hydrophobic amino acid,
with serine, a polar noncharged amino acid, at codon
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Figure 3 Whole-cell current density of human recombinant wt and F1491S calcium channels. HEK293 cells were grown in culture and
transfected with human pcDNA1a1A-2 or human pcDNA1_a 1A-2F1491S together with cDNA1_a 2bd,_pCMVb4a and pCMVCD4, as described
by Hans et al. (1999). Cells were placed into a recording chamber with Tyrode’s solution and, after attainment of the whole-cell configuration,
were perfused with the external recording solution containing 5 (for wt channel) or 10 (for mutant channel, to allow for more accurate
measurement of very small current) mM BaCl2, 148 mM TEA-Cl, and 10 mM HEPES. Internal solution contained 100 mM Cs-methanesulfonate,
5 mM MgCl2, 30 mM HEPES, 10 mM EGTA, 4 mM ATP, 0.5 mM GTP, and 1 mM c-AMP. Patch-clamp recordings were performed at room
temperature (21–25C), following standard techniques (Hamill et al. 1981), using an Axopatch-200A amplifier, were low-pass filtered at 1 kHz
and were digitized at 5 kHz. Step depolarizations, lasting 136 ms, were delivered from a holding potential of 90 mV. Compensation (typically
70%–80%) for series resistance was generally used, and only data from cells with a voltage error of !5 mV were analyzed. Current-voltage
relationships were pooled from 11 cells transfected with either wt or mutant channels. For each cell, the peak current was divided by the cell
capacitance to obtain the current density. Representative current traces at increasing test depolarizations, from a cell expressing wt channels,
are shown on the right (top: Vt p 50 to 10 mV; bottom: Vt p 20 to 50 mV).
1491 (GenBank)—that is, in the putative segment 6 of
the III protein domain (fig. 2). The only other detected
migration anomaly was in the intron between exons 23
and 24, and it consisted of an already described T/C
polymorphism at nt 4142 (Ophoff et al. 1996). Sequenc-
ing of exon 28 in the other two members of the family
(I-1 and II-1) showed a wt sequence. Typing the whole
family for 19p13 markers D19S914, D19S1150, CAGn,
and RFX1 showed that the same haplotype was shared
by the two affected subjects and the two healthy ones,
indicating that a de novo mutation arose in the pro-
band’s mother. No CAG expansion was detected in any
of the family members.
The phenotype (see also fig. 1 legend) associated with
this mutation includes vertigo episodes, sometimes so
prolonged as to require admission to a hospital, interictal
cerebellar signs of variable severity including a perma-
nent ataxia, cerebellar vermis atrophy at MRI scan, and
sensitivity to acetazolamide treatment, as in most EA2
patients (von Brederlow et al. 1995; Denier et al. 1999;
Jen et al. 1999). In addition, a strabismus and a dystonic
dyskinesia were present in both patients. Given the lack
of clinical details about the strabismus before its surgical
correction, no hypotheses can be proposed about its be-
ing purely coincidental with EA2 or part of the phe-
notype due to the mutation. It is worth noting, however,
that strabismus was part of the clinical picture of a fam-
ily, reported by Harris et al. (1993), in association with
a dominant vestibulocerebellar pattern of oculomotor
anomalies very similar to that found in EA2, but without
extraocular cerebellar signs. The presence of dystonic
features, instead, might be part of the mutation-asso-
ciated phenotype, since a severe dystonia is reported in
mice homozygotes for the null CACNA1A mutation
(Jun et al. 1999; Fletcher et al., in press). Migraine with
visual aura was present in the proband’s grandmother
(I-1) and in the maternal aunt (II-1), who does not carry
the mutation and who had a normal neurological ex-
amination. Migraine without aura was affecting the pro-
band’s mother (II-2) but not the proband herself. Mi-
graine, therefore, appears to segregate independently of
the mutation. On the whole, the phenotype, despite ex-
hibiting some peculiar features, is markedly different
from that of FHM associated with other missense mu-
tations (Battistini et al. 1999; Ducros et al. 1999) and
is fully compatible with that of EA2 (von Brederlow et
al. 1995; Denier et al. 1999; Jen et al. 1999).
To investigate its functional consequences, the mu-
tation F1491S was inserted, by standard site-directed
mutagenesis, into the human cDNA of the a1A-2 subunit
(Hans et al. 1999), which is 99.5% identical to the hu-
man BI-1 isoform (Zhuchenko et al. 1997). The wt or
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Figure 4 Immunofluorescence localization of recombinant hu-
man wt and mutant a1A subunits. Top, laser scanning confocal images
of representative HEK293 cells transfected with either wt human
a1A-2 or human a1A-2 F1491S subunits, together with b4a and a2bd sub-
units, and labeled with a specific rabbit antihuman a1A antibody pre-
pared against unique amino acid sequences residing in the cytoplasmic
intracellular loop between IIS6 and IIIS1, as described by Volsen et
al. (1995). Cell samples were mounted on 90% (v/v) glycerol, 0.2%
(w/v) N-propylgallate in PBS, and cells were viewed using the MRC-
1024 Laser Scanning Confocal Imaging System (Bio-Rad). Quantifi-
cation of the fluorescence along selected lines drawn on cells was
obtained using the LaserSharp software. The transfected cells were
identified using GFP. Scale bar: 10 mm. Untransfected GFP-negative
cells do not show any labeling by the human a1A antibody (data not
shown). Bottom, fluorescence (in arbitrary units) measured along a
line drawn on each cell. The immunofluorescence shows two rather
broad peaks of similar amplitude in cells transfected with wt and
mutant a1A subunits.
the mutant a1A-2 subunits were expressed in human em-
bryonic kidney (HEK) 293 cells, together with human
a2bd and human b4a subunits. Figure 3 shows the average
current-voltage relationships measured for wt and
F1491S mutant channels. The maximal current density
measured at 10 mV in cells expressing wt human re-
combinant P/Q-type Ca2 channels was 42.8  6 pA/
pF ( ; 5 mM Ba2), whereas in cells expressingnp 15
the mutant P/Q channels, the current density at10 mV
was pA/pF ( ; 10 mM Ba2) or1.31 0.14 np 28
pA/pF ( ; 5 mM Ba2). The small current.99 .09 np 6
measured in cells expressing the mutant channels is due
to endogenous Ca2 channels of HEK293 cells, since a
similar current was measured in untransfected HEK293
cells ( pA/pF at 10 mV, ; 10 mM1.10 .16 np 13
Ba2). The endogenous Ba2 current density, measured
after incubation of the cells with both q-CTx-MVIIC (5
mM) and q-CgTxGVIA (1 mM), was not significantly
different ( pA/pF, ), thus excluding that.95 .28 np 6
P/Q and N-type Ca2 channels significantly contribute
to this current. These results show that human a1A sub-
units containing mutation F1491S do not form func-
tional P/Q-type Ca2 channels.
To assess whether the absence of functional mutant
channels was due to lack of channel activity or to lack
of channel expression, we used a specific polyclonal an-
tihuman a1A antibody and confocal immunofluorescence
analysis to localize the subunit in HEK293 cells trans-
fected either with wt or with mutant cDNA, together
with that of auxiliary subunits. Figure 4 shows that the
level of protein expression appeared to be very similar
for wt and for mutant a1A subunits. The fluorescence
measured along a line drawn on each cell shows two
rather broad peaks, whose values (in arbitrary units)
were, on average, and , respectively,171 13 183 15
in 19 and 16 cells transfected with wt and mutant a1A
subunits. Thus, the absence of functional mutant P/Q-
type calcium channels is not due to lack of channel ex-
pression. It remains unclear whether the lack of func-
tional mutant channels is due to lack of membrane
targeting or to complete loss of function of channels
localized in the membrane.
The mutated amino acid F1491 lies in the putative
transmembrane segment IIIS6, very near the outer chan-
nel mouth, and is highly conserved across all the differ-
ent classes of voltage-gated calcium channel a1 subunits.
S6 segments are thought to contribute to the pore lining
of voltage-dependent ion channels (Armstrong and Hille
1998). Consistent with this idea, mutations in S6 seg-
ments of Ca2 channels have been shown to change sin-
gle-channel conductance (Hans et al. 1999) and channel
selectivity (Hockerman et al. 1997). Moreover, several
lines of evidence show that S6 segments contain key
elements for the voltage-dependent inactivation of Ca2
channels (Hering et al. 1998). In a chimeric rabbit-carp
a1A subunit containing the IVS6 segment of the a1C sub-
unit, the inactivation time course was slowed down by
the substitution of the phenylalanine corresponding to
human F1491 with an alanine (Hering et al. 1997).
However, it appears very unlikely that the lack of func-
tional human F1491S P/Q channels, reported here, may
be due to permanent inactivation of the channels, since
we did not measure any Ca2 current in the entire voltage
range, even with highly negative holding potentials.
Moreover, it should be assumed that the effects on in-
activation go in opposite directions, depending on
whether phenylalanine is changed to alanine or serine.
Instead, it is more likely that the presence of a serine
residue, a small hydrophilic amino acid, instead of a
phenylalanine, a larger hydrophobic amino acid, could
impair the proper folding of the protein segment, with
the consequence that it will not assume a correct position
within the membrane, grossly altering the pore structure.
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According to the latter hypothesis, it is unlikely that
other protein isoforms, not tested in the present study,
would yield results different from those obtained here.
Assuming that the mutation would display similar ef-
fects in physiologically different HEK293 and neuronal
cells, a heterozygous condition for the mutation, in vivo,
would reduce by 50% the number of functional P/Q
channels and could act through a haploinsufficiency
mechanism or, alternatively, a dominant-negative effect.
In the latter case, a competition between functional and
nonfunctional channels for regulatory-associated pro-
teins might be hypothesized. This would also provide a
possible explanation for the presence of a neurological
phenotype in heterozygous humans, in contrast with its
absence in heterozygous Cacna1a null mice—in which
protein expression is reduced by 50%, but in which only
functional P/Q channels are present in the membrane
(Fletcher et al., in press).
The present study indicates that a complete loss of P/
Q channel function is most likely the mechanism un-
derlying EA2, whether due to truncating or to missense
mutations, thus differentiating the present EA2 missense
mutation from those causing pure FHM, shown to ex-
hibit a gain rather than a loss of function (Hans et al.
1999). Whether other nontruncating mutations that
cause EA2 are also leading to a loss of function remains
to be determined. A partial loss of channel function was
also displayed by missense mutations, causing FHM
with additional cerebellar signs (Hans et al. 1999), and
by CAGn expansions (Matsuyama et al. 1999; Toru et
al. 2000), suggesting, as a working hypothesis for future
research, the possibility that a common basis underlies
the cerebellar involvement in all three allelic disorders.
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